Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
US9765107B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 16, 2014 |
| Grant date | Sep 19, 2017 |
| Priority date | — |
| Expiry date | Jun 16, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/7068
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to Cyclic Phosphonate Substituted Nucleoside Derivatives of Formula (I): (structure) and pharmaceutically acceptable salts thereof, wherein B, X, R1, R2 and R3 are as defined herein, as well as to compositions and methods of using the Cyclic Phosphonate Substituted Nucleoside Derivatives for treating or preventing HCV infection in a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.